secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIMI Holdings Inc. (—)
CIK:        0001213660
Form:       8-K
Filed at:   2023-03-15T23:59:59+00:00
Accession:  0001213900-23-020340
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.60
Item codes: 2.01, 3.02
LLM model:  deepseek-v4-flash:cloud@v2

BIMI closes acquisition of Phenix Bio for $180K cash and performance-contingent stock
--------------------------------------------------------------------------------

- Transaction closed March 15, 2023; seller is Chairman Mr. Fnu Oudom (related party).
- Total consideration: $180,000 cash paid plus up to 5,270,000 shares of common stock.
- 270,000 shares subject to shareholder approval; 5,000,000 shares issuable if Phenix generates ≥$2.5M net profit in 2023.
- Shares issued in reliance on exemption from registration under Section 4(a)(2) of the Securities Act.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1213660/000121390023020340/0001213900-23-020340-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1213660/000121390023020340/ea175263-8k_bimiinter.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-020340

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer